Comparing human pancreatic cell secretomes by in vitro aptamer selection identifies cyclophilin B as a candidate pancreatic cancer biomarker

Journal of Clinical Investigation

Volumn 122, Issue 5, 2012, Pages 1734-1741

  Ray, Partha ^a   Rialon Guevara, Kristy L ^a   Veras, Emanuela ^a   Sullenger, Bruce A ^a   White, Rebekah R ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; APTAMER M9 5; CYCLOPHILIN B; SECRETOME; TUMOR MARKER; UNCLASSIFIED DRUG;

AFFINITY LABELING; ANIMAL CELL; ARTICLE; BODY FLUID; CANCER DIAGNOSIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MASS SPECTROMETRY; MOLECULAR RECOGNITION; NONHUMAN; PANCREAS CANCER; PANCREAS CELL; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEIN STRUCTURE; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; BASE SEQUENCE; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CYCLOPHILINS; HUMANS; MICE; MICE, TRANSGENIC; PANCREAS; PANCREATIC NEOPLASMS; PROTEIN BINDING; PROTEOME; SELEX APTAMER TECHNIQUE; TUMOR MARKERS, BIOLOGICAL;

EID: 84860579546     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI62385     Document Type: Article

References (42)

1. Howlader N, et al. SEER Cancer Statistics Review, 1975-2008. Bethesda, Maryland, USA: National Cancer Institute; 2011.
2. Goonetilleke KS, Siriwardena AK. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol. 2007;33(3):266-270. (Pubitemid 46488663)
3. Tempero MA, Uchida E, Takasaki H, Burnett DA, Steplewski Z, Pour PM. Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer. Cancer Res. 1987;47(20):5501-5503. (Pubitemid 17152971)
4. Hanash SM, Pitteri SJ, Faca VM. Mining the plasma proteome for cancer biomarkers. Nature. 2008; 452(7187):571-579. (Pubitemid 351483371)
5. Makridakis M, Vlahou A. Secretome proteomics for discovery of cancer biomarkers. J Proteomics. 2010;73(12):2291-2305.
6. Gronborg M, et al. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics. 2006;5(1):157-171. (Pubitemid 43169348)
7. Mauri P, et al. Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers. FASEB J. 2005;19(9):1125-1127. (Pubitemid 40946439)
8. Sasaki K, Sato K, Akiyama Y, Yanagihara K, Oka M, Yamaguchi K. Peptidomics-based approach reveals the secretion of the 29-residue COOH-terminal fragment of the putative tumor suppressor protein DMBT1 from pancreatic adenocarcinoma cell lines. Cancer Res. 2002;62(17):4894-4898. (Pubitemid 34984410)
9. Huo Q. Protein complexes/aggregates as potential cancer biomarkers revealed by a nanoparticle aggregation immunoassay. Colloids Surf B Biointerfaces. 2010;78(2):259-265.
10. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature. 1990;346(6287):818-822.
11. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 1990; 249(4968):505-510.
12. Ishizaki J, Nevins JR, Sullenger BA. Inhibition of cell proliferation by an RNA ligand that selectively blocks E2F function. Nat Med. 1996;2(12):1386-1389.
13. Jenison RD, Gill SC, Pardi A, Polisky B. High-resolution molecular discrimination by RNA. Science. 1994;263(5152):1425-1429. (Pubitemid 24137828)
14. Yang X, et al. Selection of thioaptamers for diagnostics and therapeutics. Ann N Y Acad Sci. 2006; 1082:116-119. (Pubitemid 44955456)
15. Gold L, et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PloS One. 2010;5(12):e15004.
16. Knudsen SM, Robertson MP, Ellington AD. In vitro selection using modified or unnatural nucleotides. Curr Protoc Nucleic Acid Chem. 2002; Chapter 9:Unit 9.6.
17. Ostroff RM, et al. Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer. PloS One. 2010;5(12):e15003.
18. Furukawa T, Duguid WP, Rosenberg L, Viallet J, Galloway DA, Tsao MS. Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. Am J Pathol. 1996; 148(6):1763-1770. (Pubitemid 26171674)
19. Ouyang H, et al. Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype. Am J Pathol. 2000;157(5):1623-1631.
20. Olive KP, et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science. 2009; 324(5933):1457-1461.
21. Liby KT, et al. Synthetic triterpenoids prolong survival in a transgenic mouse model of pancreatic cancer. Cancer Prev Res (Phila). 2010;3(11):1427-1434.
22. Price ER, Zydowsky LD, Jin MJ, Baker CH, McKeon FD, Walsh CT. Human cyclophilin B: a second cyclophilin gene encodes a peptidyl-prolyl isomerase with a signal sequence. Proc Natl Acad Sci U S A. 1991;88(5):1903-1907. (Pubitemid 21916335)
23. Fang X, Tan W. Aptamers generated from cell- SELEX for molecular medicine: a chemical biology approach. Acc Chem Res. 2010;43(1):48-57.
24. Shangguan D, et al. Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci U S A. 2006;103(32):11838-11843. (Pubitemid 44215773)
25. Mallikaratchy P, Tang Z, Kwame S, Meng L, Shang guan D, Tan W. Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt's lymphoma cells. Mol Cell Proteomics. 2007;6(12):2230-2238.
26. Sefah K, Meng L, Lopez-Colon D, Jimenez E, Liu C, Tan W. DNA aptamers as molecular probes for colorectal cancer study. PloS One. 2010;5(12):e14269.
27. Hicke BJ, et al. Tenascin-C aptamers are generated using tumor cells and purified protein. J Biol Chem. 2001;276(52):48644-48654.
28. Mi J, et al. In vivo selection of tumor-targeting RNA motifs. Nat Chem Biol. 2010;6(1):22-24.
29. Kay JE. Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases. Biochem J. 1996; 314(pt 2):361-385.
30. Hasel KW, Glass JR, Godbout M, Sutcliffe JG. An endoplasmic reticulum-specific cyclophilin. Mol Cell Biol. 1991;11(7):3484-3491. (Pubitemid 21895735)
31. Spik G, et al. A novel secreted cyclophilin-like protein (SCYLP). J Biol Chem. 1991;266(17):10735-10738. (Pubitemid 21906865)
32. Fang F, Flegler AJ, Du P, Lin S, Clevenger CV. Expression of cyclophilin B is associated with malignant progression and regulation of genes implicated in the pathogenesis of breast cancer. Am J Pathol. 2009; 174(1):297-308.
33. Gomi S, et al. A cyclophilin B gene encodes antigenic epitopes recognized by HLA-A24-restricted and tumor-specific CTLs. J Immunol. 1999; 163(9):4994-5004. (Pubitemid 29501267)
34. Mizukoshi E, et al. Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma. Hepatology. 2011;53(4):1206-1216.
35. Kim Y, et al. Role of cyclophilin B in tumorigenesis and cisplatin resistance in hepatocellular carcinoma. Hepatology. 2011;54(5):1661-1678.
36. Borta H, et al. Analysis of low abundance membrane-associated proteins from rat pancreatic zymogen granules. J Proteome Res. 2010;9(10):4927-4939.
37. Liao DF, et al. Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells. J Biol Chem. 2000; 275(1):189-196.
38. Liu JW, et al. Induction of prosurvival molecules by apoptotic stimuli: involvement of FOXO3a and ROS. Oncogene. 2005;24(12):2020-2031.
39. Koong AC, et al. Pancreatic tumors show high levels of hypoxia. Int J Radiat Oncol Biol Phys. 2000; 48(4):919-922.
40. Li Y, Lee HJ, Corn RM. Detection of protein biomarkers using RNA aptamer microarrays and enzymatically amplified surface plasmon resonance imaging. Anal Chem. 2007;79(3):1082-1088.
41. Layzer JM, Sullenger BA. Simultaneous generation of aptamers to multiple gamma-carboxyglutamic acid proteins from a focused aptamer library using DeSELEX and convergent selection. Oligonucleotides. 2007;17(1):1-11. (Pubitemid 46651423)
42. Wong I, Lohman TM. A double-filter method for nitrocellulose-filter binding: application to protein- nucleic acid interactions. Proc Natl Acad Sci U S A. 1993;90(12):5428-5432. (Pubitemid 23176173)